Market cap
$1.5m
End-of-day close multiplied by current shares on issue.
IPR · NZX
Iperion is an NZX-listed construction & materials / critical minerals company with FY21 - FY26 of published result briefings.
Snapshot
FY26, released 29 May 2026
| Metric | Value | Change |
|---|---|---|
| Revenue | $0m | — |
| Operating profit | -$0.3m | ↑ +33.6% |
| NPAT | -$0.3m | ↑ +32.4% |
| Operating cash flow | -$0.27m | ↑ +38.6% |
| OCF / Operating profit % | 91.5% | ↓ -7.6pp |
| ROE % | n/m | — |
| DPS | 0.0c | — |
| Payout ratio vs NPAT % | n/m | — |
| PBT | -$0.3m | ↑ +32.4% |
| FCF pre-lease | -$0.28m | ↑ +37.9% |
Source: latest published briefing (FY26, released 29 May 2026). Change compares against the prior equivalent period: FY25, released 29 May 2025.
Valuation
A compact read on what the market price implies next to the latest filing data. The numbers are a starting point for comparison, not a recommendation.
The latest close and share count context for the market price.
Market cap
$1.5m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
Not available
Not meaningful when recent earnings are negative.
EPS
-0.00
Recent filing-derived earnings per share.
PEG
Not available
Not available for this company right now.
EV/EBITDA
Not available
Not meaningful when recent EBITDA is negative.
P/FCF
Not available
Not meaningful when free cash flow is negative or unavailable.
P/B
28.61x
Market value compared with latest reported equity.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
0.0%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Daily closes use the full available width, with hover and touch readouts against real observations. Expand opens the chart at reading size.
Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.
Chat
Ask follow-up questions about Iperion's latest result and company history.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Longitudinal view
The latest period is shown first.
| Metric | FY2612 MONTHS29 May 2026 | HY266 MONTHS24 November 2025 | FY2512 MONTHS29 May 2025 | HY256 MONTHS28 November 2024 | FY2412 MONTHS29 May 2024 | HY246 MONTHS29 November 2023 | FY2312 MONTHS30 May 2023 | HY236 MONTHS29 November 2022 | FY2212 MONTHS30 May 2022 | HY226 MONTHS29 November 2021 | FY2112 MONTHS31 May 2021 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0m | $0m | $0m | $0m | $0m | $0m | $0.03m | $0.01m | $0m | $0m | $0.03m | Chart |
| Revenue growth % | -100.0% | — | — | — | -100.0% | -100.0% | -99.8% | 150.0% | -100.0% | -100.0% | -100.0% | Chart |
| Operating profit | -$0.3m | — | -$0.44m | — | -$0.8m | -$0.48m | -$0.28m | -$0.13m | — | — | — | Chart |
| Operating profit margin % | — | — | — | — | — | — | n/m | n/m | — | — | — | Chart |
| PBT | -$0.3m | — | -$0.44m | — | -$0.8m | — | -$0.3m | -$0.1m | — | -$0.1m | -$0.1m | Chart |
| NPAT | -$0.3m | — | -$0.44m | — | -$0.8m | — | -$0.3m | — | — | -$0.1m | -$0.1m | Chart |
| Operating cash flow | -$0.27m | -$0.18m | -$0.44m | -$0.27m | -$0.73m | -$0.37m | -$0.41m | -$0.14m | -$0.12m | -$0.07m | -$0.12m | Chart |
| OCF / Operating profit % | 91.5% | — | 99.1% | — | 90.3% | 76.8% | 145.7% | 104.5% | — | — | — | Chart |
| FCF pre-lease | -$0.28m | -$0.18m | -$0.45m | -$0.27m | -$0.73m | — | — | — | — | — | — | Chart |
| FCF post-lease | -$0.28m | — | -$0.45m | -$0.27m | — | — | — | — | — | — | — | Chart |
| DPS | 0.0c | — | — | — | — | — | — | — | — | — | — | — |
| Payout ratio vs NPAT % | n/m | — | — | — | — | — | — | — | — | — | — | — |
| ROE % | n/m | — | -75.6% | — | -0.1% | — | -17.2% | — | — | -5.4% | -5.7% | Chart |
| Total assets | $0.18m | $0.27m | $0.45m | $0.62m | $0.9m | $1.3m | $1.7m | $1.9m | $2m | $2.1m | $2.2m | Chart |
Reference: annolyse.ai/companies/ipr
Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.
These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.
Reported revenue across covered periods.
Like-period revenue growth where comparable.
Company-specific earnings measure where disclosed.
Statutory profit after tax.
Cash generated from operations.
Operating cash flow less capex before leases.
Additional verified filing metrics for this company. Each point links back to a published briefing period in the source data contract.
Free cash flow after lease payments where available.
Return on equity.
Dividend per share declared for the period.
The setup & the reality
The latest result is checked against what the prior briefing said to watch.
Historical setup
Previous analysisHY26Result releasedAnnolyse analysis published
From Iperion's asset base fell to NZ$0.3m, the smallest on record
No forward targets, guidance, or forward-work disclosures are provided. The supplied shape context shows HY25 carried 82% of FY25's NPAT and 60.9% of FY25's operating cash outflow, so on that pattern alone the second half could imply a smaller incremental loss than the first. That extrapolation is fragile because revenue is zero, cost behaviour is largely discretionary, and the implied FY25 second-half NPAT of –NZ$0.1m was itself small in absolute terms.
What the release does not support is any view on when, or whether, the antimicrobial licence will begin generating royalty income at the disclosed minimum levels. Without that, the result tells the reader how much burn occurred this half, not what the run-rate becomes once the licence activates.
Open questions
This briefing cannot assess the operational status of the antimicrobial licence, the recoverability of remaining intangible assets, or the company's ability to fund continued operations beyond the cash currently on hand.
Archive
Every published Annolyse briefing for this company appears here in reverse chronological order.
FY26 · Released 29 May 2026
Operating losses keep absorbing the balance sheet; total equity fell 84.5% to NZ$0.1m while the Pathoglaze licence still produces no revenue.
HY26 · Released 24 November 2025
The half-year loss narrowed and cash burn eased, but with zero revenue the company is operating from its lowest asset base in the supplied historical
FY25 · Released 29 May 2025
Zero revenue persisted while equity dropped 55.8% and the asset base hit a historical low, leaving runway as the dominant question.
HY25 · Released 28 November 2024
The smaller HY25 loss is cost-base contraction, not progress, with NZ$0.1m of cash facing a NZ$0.3m half-year operating burn.
FY24 · Released 29 May 2024
The reported 99.7% NPAT improvement is a scale artefact: a near-complete contraction of the balance sheet leaves cash burn outrunning cash on hand.
HY24 · Released 29 November 2023
An effectively dormant shell burned through its remaining NZ$0.7m of cash while the operating loss more than tripled to NZ$0.5m.
FY23 · Released 30 May 2023
The 99.8% PBT "improvement" reflects a completed transition out of a $2.0bn-asset predecessor, not operating progress in the new entity.
HY23 · Released 29 November 2022
Interest income up 150% from a tiny base sets an unprecedented growth rate, but Southern Charter remains pre-revenue after the issuer transition.
FY22 · Released 30 May 2022
Total assets fell from NZ$2,154.5m to NZ$2.0m through an issuer transition, leaving zero revenue and only NZ$22k of cash.
HY22 · Released 29 November 2021
Headline -100.0% revenue and +99.8% loss narrowing reflect corporate change, not operating performance; NZ$44k cash limits acquisition capacity.
FY21 · Released 31 May 2021
An issuer transition from SNC and an unresolved acquisition search leave the read as a pre-deployment cash vehicle, not an operating result.
Get the next Iperion result briefing and five-year history updates by email.